News Daily News Use of Secondary CVD Prevention Meds Still Meager Worldwide Caitlin E. Cox February 03, 2025
News Industry News Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients January 30, 2025
News Daily News AHA Stats Show CV Health of Americans Remains Dire Michael O'Riordan January 28, 2025
News Daily News DRIVE-STEMI Supports Less Restrictive Driving Guidance After Acute MI L.A. McKeown January 23, 2025
News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025
News Daily News Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates L.A. McKeown January 10, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2024 Caitlin E. Cox December 31, 2024
News Daily News BMJ Investigation Revives Questions About PLATO, Ticagrelor Todd Neale December 20, 2024
News Daily News PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits Michael O'Riordan December 18, 2024
News Daily News Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3 Todd Neale December 09, 2024
News Daily News Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD Todd Neale December 06, 2024
News Daily News CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy Todd Neale December 04, 2024
Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
News Conference News AHA 2024 GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes Michael O'Riordan November 17, 2024
News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024